REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eusol Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Eusol Biotech Co., Ltd. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Eusol Biotech Co., Ltd. is mainly engaged in the research, development, manufacture and sale of human acid fibroblast growth factor protein with medical effects. The company was founded in 2005 and is headquartered in Taipei City, Taiwan.

Headquarters
6F.,No.135, Sec.3, Minsheng E. Rd., Songshan Dist
Taipei City; Taipei City;

Contact Details: Purchase the Eusol Biotech Co., Ltd. report to view the information.

Website: http://www.eusol.com.tw

Basic Information
Total Employees:
Purchase the Eusol Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Eusol Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Eusol Biotech Co., Ltd. report to view the information.
Incorporation Date:
March 16, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
23.72%
Purchase this report to view the information.
2.34%
Purchase this report to view the information.
1.46%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Sequential Medicine Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Eusol Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-3.01%▼
EBITDA
-22.15%▼
Net Profit (Loss) for the Period
13.44%▲
Total assets
-7.64%▼
Total equity
-7.95%▼
Return on Equity (ROE)
0.26%▲
Quick Ratio
-15.67%▼
Cash Ratio
4.37%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
TWI Biotechnology, Inc.
 
Original Biomedicals Co., Ltd.
Launxp Biomedical Co., Ltd.
 
United BioPharma, Inc.
CHO Pharma, Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo